Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low vs High Dose Tranexamic Acid in Adult Spinal Deformity Surgery
NCT02053363Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2014
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in adult spinal deformity (ASD) (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Intraoperative Blood Loss at 8 hours. Started Mar 2014; status: completed.
02
Drugs
tranexamic acid
03
Conditions
adult spinal deformity (ASD)
Beyond the preview
Go deeper on NCT02053363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053363.